Dr. Wahlster is studying the developmental origins of acute lymphoblastic leukemia (ALL), the most common childhood cancer and leading cause of death in children. The goal of Dr. Wahlster’s research is to understand the biological processes that drive blood cancer development. Applying innovative genomic tools, her work seeks to decipher how cancer-predisposing genetic variants impact early blood cell development and facilitate the acquisition of secondary genetic changes found in ALL. She aims to leverage these insights to guide the development of novel, mechanism-based treatments. Dr. Wahlster earned her MD and PhD from the University of Heidelberg, Heidelberg.
Damon Runyon Researchers
Meet Our Scientists
Lara Wahlster, MD, PhD
Project title: "Decoding mechanisms of B-acute lymphoblastic leukemia pathogenesis through the lens of genomics"
Institution: Dana-Farber Cancer Institute
Award Program: St. Jude Fellow
Sponsor(s) / Mentor(s): Vijay G. Sankaran, MD, PhD
Cancer Type: Blood
Research Area: Cancer Genetics
